Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis

Figure 2

Comparison of survival rates regarding therapeutic responses and additional treatments. (a) Comparison of the overall therapeutic response of HCC; patients with a therapeutic response (CR, PR; ) had a significant better survival curve than patients without a therapeutic response (SD, PD; ) (). CR: complete response, PR: partial response, SD: stable disease, and PD: progression disease. (b) Patients who had received additional locoregional therapy () experienced significantly better survival as compared with patients who were unable to receive locoregional therapy () (). (c) No statistical difference in survival rates in terms of sorafenib treatment () and no sorafenib treatment () ().

(a)

(b)

(c)